Prime Minister Narendra Modi highlights Gramajanya Farmers' Producer Company in Puttur during Mann Ki Baat. Director Ramapratheek Kariyal calls it a major boost for farmer activities. Read more.
A 51-year-old Mumbai businesswoman was held at gunpoint, stripped and threatened by pharmaceutical company executives. Mumbai Police registers case under multiple sections.
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Indian-American billionaire Vivek Ramaswamy's fortune surges to $1.8B despite political setbacks. Discover how his pharma investments fueled this remarkable growth and his Ohio governor campaign.
Aurobindo Pharma's China facility currently faces $1M loss but aims for break-even by Q3-Q4 FY26. CFO outlines growth drivers including Pen-G ramp-up and biosimilar commercialization.
Karnataka Health Minister Dinesh Gundu Rao urges the pharma sector to adhere to regulations, highlighting critical public health and industry credibility issues.
Global technology firm SMC Squared recognized in 2025 SMU Cox Dallas 100 list, marking their third appearance on this prestigious ranking of fastest-growing companies.
Global technology firm SMC Squared named 2025 SMU Cox Dallas 100 winner, marking third appearance on prestigious growth companies list. Discover their success story.
AVP Infracon Limited reports stellar H1 FY2024 performance with 79% revenue growth and 82% net profit increase. Strong order book signals continued expansion in infrastructure sector.
India-US trade deal negotiations advance with $500 billion bilateral trade target by 2030. Experts reveal which Indian stocks could benefit most from tariff easing.
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
A smallcap pharma stock listed on NSE defied market trends with a 10% surge on November 21, 2024. Discover the driving factors behind this remarkable performance.
Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.
Tragic boiler explosion at pharmaceutical factory in Pakistan's Punjab province claims 15 lives, leaves dozens injured. Emergency response underway.
OPPI Annual Summit 2025 highlights strategic partnerships accelerating India's pharmaceutical transformation. Discover key insights from industry leaders.
Sudeep Pharma's ₹895 crore IPO opens with ₹563-593 price band. Grey market shows ₹130 premium. Analysts recommend long-term investment for 2-5 years horizon.
Sudeep Pharma's ₹895 crore IPO opens today. Price band ₹563-593 per share. Learn about company details, investment minimums & global presence. Subscribe now!
India strengthens ties with Seychelles by delivering 3.5 tonnes of essential medicines. This humanitarian gesture showcases India's commitment to global health partnerships.
Sudeep Pharma's ₹95 crore IPO opens November 21 with strong grey market premium. Learn price band, dates, financials & investment details for this pharma ingredients maker.
Target Corporation reduces 2025 earnings forecast amid restructuring and soft demand. Retailer plans $5 billion capital spending boost while shares decline 2% in early trading.
Sudeep Pharma's ₹895 crore IPO opens November 21-25. Price band ₹563-593 per share. Company manufactures pharmaceutical excipients and speciality ingredients.
Microsoft India reports impressive 38.66% profit growth reaching ₹1,245.18 crore in FY2025. Revenue surges 28% to ₹29,303 crore. Discover the key factors behind this stellar performance.
Remedium Lifecare reports stellar Q2 results with profit nearly doubling to ₹38.62 crore. Revenue surges 22% driven by strong pharmaceutical exports and domestic growth.
Evexia Lifecare share price gained over 3% with heavy trading volumes. Discover the Q2 FY26 results showing a sharp profit fall and the stock's long-term decline. Read analysis before investing.
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.
Hvax Technologies announces impressive 35% growth in total income for H1 FY26, reaching ₹5.95 crore. The company shows strong financial performance with significant profit improvements.
Punjab Health Minister Dr Balbir Singh issues strict quality warning to drug manufacturers after MP cough syrup incident. State adopts zero-tolerance policy on sub-standard medicines.
India requests Russia to expedite approvals for Indian exporters in marine, pharmaceutical sectors during Moscow talks. Bilateral trade targets $100B by 2030. Key discussions ahead of Putin's December visit.
FSSAI cracks down on false ORS marketing claims. FDC Ltd welcomes action, reaffirming Electral's 50-year scientific legacy as genuine electrolyte solution.
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.